Palvella Therapeutics (PVLA) EBITDA Margin (2015 - 2024)
Palvella Therapeutics (PVLA) posted EBITDA Margin of -3375.47% for Q1 2024, down 2633.88 percentage points from -741.59% a year earlier and down 4390.71 percentage points from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) EBITDA Margin (2015 - 2024) Analysis & Trends
For FY2023, Palvella Therapeutics' EBITDA Margin came in at -23.28%, up 133.87 percentage points from FY2022.
- Annual EBITDA Margin shows a five-year change of +80.61 percentage points (FY2018 to FY2023).
- In prior years, Palvella Therapeutics' EBITDA Margin was -157.15% in FY2022 (unchanged), -157.15% in FY2021 (-49.35 pp), -107.80% in FY2020 (-50.48 pp) and -57.32% in FY2019 (+46.57 pp).
- The Q1 2024 figure stands as the lowest quarterly EBITDA Margin in data going back to Q1 2015.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of -159.45 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2023, with a gain of 1202.45 percentage points; the weakest was Q1 2024, with a drop of 2633.88 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 1015.24% (Q4 2023), -56.70% (Q3 2023) and 14.04% (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -3,375.47% |
| Dec 31, 2023 | 1,015.24% |
| Sep 30, 2023 | -56.70% |
| Jun 30, 2023 | 14.04% |
| Mar 31, 2023 | -741.59% |
| Dec 31, 2022 | -187.20% |
| Sep 30, 2022 | -212.31% |
| Jun 30, 2022 | -317.66% |
| Mar 31, 2022 | -59.14% |
| Dec 31, 2021 | -123.06% |
| Sep 30, 2021 | -453.64% |
| Jun 30, 2021 | -491.45% |
| Dec 31, 2020 | -624.56% |
| Sep 30, 2020 | -416.64% |
| Jun 30, 2020 | -36.68% |
| Mar 31, 2020 | -26.52% |
| Dec 31, 2019 | -6.17% |
| Sep 30, 2019 | -18.21% |
| Jun 30, 2019 | -228.58% |
| Mar 31, 2019 | -123.08% |
API Access
Palvella Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();